Barclays PLC Sells 15,070 Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN)
Barclays PLC cut its position in shares of Dyne Therapeutics, Inc. (NASDAQ:DYN – Free Report) by 7.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 192,239 shares of the company’s stock after selling 15,070 shares during the quarter. Barclays PLC owned approximately 0.19% […]
Barclays PLC cut its position in shares of Dyne Therapeutics, Inc. (NASDAQ:DYN – Free Report) by 7.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 192,239 shares of the company’s stock after selling 15,070 shares during the quarter. Barclays PLC owned approximately 0.19% […]
